e-learning
resources
Paris 2018
Sunday, 16.09.2018
Translational models of the immunopathology that underlies airway obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
J. Kelly (Southampton, United Kingdom), E. Davies (Cincinnati, United States of America), X. Xu (Cincinnati, United States of America), J. Whitsett (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom)
Source:
International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Session:
Translational models of the immunopathology that underlies airway obstructive diseases
Session type:
Thematic Poster
Number:
1103
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kelly (Southampton, United Kingdom), E. Davies (Cincinnati, United States of America), X. Xu (Cincinnati, United States of America), J. Whitsett (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom). Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation. 1103
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Relevance of innate immune responses to chronic airway diseases
Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences
Year: 2008
The innate immune function of airway epithelial cells in inflammatory lung disease
Source: Eur Respir J 2015; 45: 1150-1162
Year: 2015
Apolipoprotein A1 regulate innate immune response and tight junction formation in the airway epithelium to promote the resolution of allergic airway inflammation
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012
Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
How innate immunity regulates adaptive immunity
Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases
Year: 2006
Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007
Characterisation of type two immune responses in a murine model of allergic airway disease
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
A pathogen-activated innate homing pathway that instructs allergic inflammation
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
The role of ACN9 in the inflammatory response in the airway
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Cathelicidin modulates the epithelial innate immune response to endotoxin
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003
T-cell co-stimulatory molecules: their role in allergic immune reactions
Source: Eur Respir J 2007; 29: 1246-1255
Year: 2007
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Source: Eur Respir J 2008; 32: 1068-1081
Year: 2008
IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease
Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019
Year: 2021
γδ T cells contribute to local and systemic B cell reactivity in allergic eosinophilic airway inflammation but without a major influence on the TH1/TH2 balance
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Rhinovirus induced innate immune responses in the epithelium of severe COPD
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling
Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Year: 2007
Signs of MICA as an innate immune molecule potentially involved in vascular remodelling in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Exercise and airway physiology: interactions with immune and allergic responses
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=10
Year: 2005
Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept